Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia
- PMID: 27747122
- PMCID: PMC5055947
- DOI: 10.1155/2016/2329483
Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia
Abstract
We describe a case of a paediatric patient affected by mandibular fibrous dysplasia (FD) with severe and chronic pain who was successfully treated with zoledronic acid (ZOL): a third-generation bisphosphonate. Further research is needed to assess its safety and efficacy as a treatment option for FD in the paediatric population.
Conflict of interest statement
The authors declare they have no conflict of interests regarding the publication of this paper.
Figures
References
-
- Jundt G. Pathologic-anatomic characteristics of benign bone tumors. Der Orthopäde. 1995;24(1):2–14. - PubMed
-
- Hart W., Schweitzer D. H., Slootweg P. J., Grootenhuis L. S. J. A male with cherubism. Nederlands Tijdschrift voor Geneeskunde. 2000;144(1):34–38. - PubMed
-
- Zumkeller W., Jassoy A., Lebek S., Nagel M. Clinical, endocrinological and radiography features in a child with McCune-Albright syndrome and pituitary adenoma. Journal of Pediatric Endocrinology and Metabolism. 2001;14(5):553–559. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources